Volume 60, Issue 5, Pages (November 2011)

Slides:



Advertisements
Similar presentations
Volume 167, Issue 6, Pages (June 2002)
Advertisements

Volume 59, Issue 2, Pages (February 2011)
The PSA Era is not Over for Prostate Cancer
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Response to Nivolumab in a Patient With Metastatic Clear Cell Renal Cell Carcinoma and End-stage Renal Disease on Dialysis  Maria I. Carlo, Darren R.
Volume 63, Issue 2, Pages (February 2013)
Volume 63, Issue 5, Pages (May 2013)
Global Trends in Testicular Cancer Incidence and Mortality
The Role of Tobacco Smoke in Bladder and Kidney Carcinogenesis: A Comparison of Exposures and Meta-analysis of Incidence and Mortality Risks  Marcus G.
Volume 61, Issue 5, Pages (May 2012)
Volume 61, Issue 5, Pages (May 2012)
Volume 51, Issue 1, Pages (January 2007)
Volume 52, Issue 3, Pages (September 2007)
Volume 51, Issue 4, Pages (April 2007)
Volume 69, Issue 1, Pages 4-6 (January 2016)
Lymph Node Dissection in Renal Cell Carcinoma
Histologic Grading of Noninvasive Papillary Urothelial Neoplasms
Volume 53, Issue 5, Pages (May 2008)
Volume 70, Issue 5, Pages (November 2016)
The Role of Residual Tumor Resection in Patients with Metastatic Renal Cell Carcinoma and Partial Remission following Immunochemotherapy  Olaf A. Brinkmann,
Ziya Kirkali, Hein Van Poppel  European Urology 
Volume 68, Issue 1, Pages (July 2015)
Prostate Cancer Epidemic in Sight?
Volume 50, Issue 5, Pages (November 2006)
Volume 59, Issue 2, Pages (February 2011)
Treatment of Advanced and Metastatic Renal Cancer: A Revolution?
Volume 59, Issue 2, Pages (February 2011)
Volume 66, Issue 2, Pages (August 2014)
Tumour Grade, Treatment, and Relative Survival in a Population-based Cohort of Men with Potentially Curable Prostate Cancer  Sam Ladjevardi, Gabriel Sandblom,
The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.
Volume 68, Issue 5, Pages (November 2015)
Volume 54, Issue 4, Pages (October 2008)
Volume 61, Issue 5, Pages (May 2012)
Volume 52, Issue 5, Pages (November 2007)
Volume 68, Issue 1, Pages 5-7 (July 2015)
Prostate Cancer Detection: A View of the Future
Volume 66, Issue 5, Pages (November 2014)
Volume 63, Issue 5, Pages (May 2013)
Shaheen Alanee, Kasmintan Schrader, Kenneth Offit  European Urology 
International Society of Urological Pathology Grading and Other Prognostic Factors for Renal Neoplasia  Brett Delahunt, John R. Srigley, Lars Egevad,
Prostate Cancer Epidemic in Sight?
The PSA Era is not Over for Prostate Cancer
Volume 50, Issue 3, Pages (September 2006)
Global Burden of Urologic Cancers, 1990–2013
Volume 74, Issue 3, Pages (September 2018)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Leonard S. Marks, Jiaoti Huang  European Urology 
Volume 63, Issue 3, Pages (March 2013)
Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review  Sven van.
Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia
Volume 59, Issue 1, Pages (January 2011)
Volume 60, Issue 6, Pages (December 2011)
Volume 56, Issue 5, Pages (November 2009)
Volume 63, Issue 6, Pages (June 2013)
Volume 50, Issue 5, Pages (November 2006)
Mammalian Target of Rapamycin Inhibitors in Clinical Practice: Case Reports of Everolimus in Renal Cell Carcinoma  Sergio Bracarda, Alain Ravaud, Marino.
Surgical Management of Renal Cell Carcinoma (RCC) with Vena Cava Tumour Thrombus  Emanuele Belgrano, Carlo Trombetta, Salvatore Siracusano, Giorgio Carmignani,
Testicular Cancer Variations in Time and Space in Europe
Volume 53, Issue 1, Pages (January 2008)
Volume 63, Issue 2, Pages (February 2013)
Sergio Bracarda  European Urology Supplements 
European Urology is “Your” Journal
Epidemiology of Renal Cell Carcinoma
Volume 51, Issue 6, Pages (June 2007)
Clinical Management of Patients Receiving Tyrosine Kinase Inhibitors for Advanced Renal Cell Carcinoma  Jan Roigas  European Urology Supplements  Volume.
Annika Berntsen, Poul F. Geertsen, Inge Marie Svane  European Urology 
Joaquim Bellmunt  European Urology Supplements 
Ian W. Mills, Anna Crossland, Anup Patel, Henrikas Ramonas 
Jan Roigas  European Urology Supplements 
Volume 51, Issue 5, Pages (May 2007)
Presentation transcript:

Volume 60, Issue 5, Pages 975-982 (November 2011) Metastatic Potential in Renal Cell Carcinomas ≤7cm: Swedish Kidney Cancer Quality Register Data  Eirikur Guðmundsson, Henrik Hellborg, Sven Lundstam, Stina Erikson, Börje Ljungberg  European Urology  Volume 60, Issue 5, Pages 975-982 (November 2011) DOI: 10.1016/j.eururo.2011.06.029 Copyright © 2011 European Association of Urology Terms and Conditions

Fig. 1 Proportion of incidentally detected renal cell carcinoma (RCC) in relation to tumor size in 2033 patients with RCC. The numbers under each column show incidentally detected patients as well as total number of patients. European Urology 2011 60, 975-982DOI: (10.1016/j.eururo.2011.06.029) Copyright © 2011 European Association of Urology Terms and Conditions

Fig. 2 Distribution of gender and age in 2033 patients with renal cell carcinoma. The numbers below show the distribution of genders relative to tumor size. European Urology 2011 60, 975-982DOI: (10.1016/j.eururo.2011.06.029) Copyright © 2011 European Association of Urology Terms and Conditions

Fig. 3 Distribution of Fuhrman high-grade (G3-G4) and low-grade (G1-G2) tumors relative to tumor size in 1725 patients with registered grade. Tumors reported as GX (n=192) and those patients without reported histopathologic grade (n=116) are included. European Urology 2011 60, 975-982DOI: (10.1016/j.eururo.2011.06.029) Copyright © 2011 European Association of Urology Terms and Conditions

Fig. 4 Occurrence of lymph node and/or distant metastases relative to tumor size in 2018 patients with renal cell carcinoma. The dashed lines show upper and lower limits of the 95% confidence interval. Fifteen patients (0.7%) with missing data on N or M category were excluded. European Urology 2011 60, 975-982DOI: (10.1016/j.eururo.2011.06.029) Copyright © 2011 European Association of Urology Terms and Conditions